Thursday 17 July 2025

The Pharma Letter Podcast — Episode 14 — A vaccine for Alzheimer's?

Biotechnology
Simon Wentworth
6 June 2022
episode14-big


More on this story...

Biotechnology
Encouraging early results in Alzheimer's for Prothena
26 July 2021
Biotechnology
Roche and Prothena move forward with PD drug prasinezumab
22 October 2020
Biotechnology
Roche's 10-year Alzheimer's study yields depressingly familiar result
16 June 2022
Pharmaceutical
Athira decimated by dismal Alzheimer's results
23 June 2022


Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

Kowa and Nicox sign further deal over glaucoma treatment
Pharmaceutical
Kowa and Nicox sign further deal over glaucoma treatment
17 July 2025
Pharmaceutical
Allen Institute and ASAP to work on expanding brain cell atlas
17 July 2025
Biotechnology
One raises $16 million to accelerate tumor profiling platform
17 July 2025
Pharmaceutical
BMS and Pfizer announce direct-to-patient Eliquis option
17 July 2025
Biotechnology
Innovator and biosimilar drug approvals in 2024 down on prior year
17 July 2025
Pharmaceutical
Grifols to invest 160M euros in new manufacturing site
17 July 2025
Biotechnology
SandboxAQ and iOncologi link up on mRNA vaccine for glioblastoma
17 July 2025

Company Spotlight

A clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.




More Features in Biotechnology

One raises $16 million to accelerate tumor profiling platform
17 July 2025
Innovator and biosimilar drug approvals in 2024 down on prior year
17 July 2025
SandboxAQ and iOncologi link up on mRNA vaccine for glioblastoma
17 July 2025
UK approval for Roche combination
17 July 2025


Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze